652P BT8009 monotherapy in enfortumab vedotin (EV)-naïve patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1
Autor: | Reig Torras, O., Crouzet, L., Necchi, A., Baldini, C., Lostes Bardaji, M.J., Doger de Spéville, B., Italiano, A., Verlingue, L., Boni, V., Carter, L., Duran, I., Garmezy, B., Galsky, M.D., Falchook, G.S., DeMars, L., Josephs, K., Xu, C., Bader, J., Fontana, E. |
---|---|
Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S515-S516 |
Databáze: | ScienceDirect |
Externí odkaz: |